The M230L mutation in HIV-1 reverse transcriptase (RT) is associated with resistance to first-generation nonnucleoside reverse transcriptase inhibitors (NNRTIs). The present study was designed to ...
The essential role of reverse transcription in the HIV life cycle is illustrated by the fact that half of the ∼30 FDA-approved drugs for HIV treatment target HIV-1 reverse transcriptase (RT). Even ...
Promega Corporation a signé un partenariat stratégique avec Watchmaker Genomics pour autoriser une nouvelle transcriptase inverse modifiée. Conçue pour apporter une précision et une sensibilité ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback